MEDOVEX CORP's ticker is MDVX and the CUSIP is 58504H101. A total of 6 filers reported holding MEDOVEX CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $13,000 | -27.8% | 10,000 | -16.7% | 0.01% | -37.5% |
Q3 2016 | $18,000 | +12.5% | 12,000 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $16,000 | +23.1% | 12,000 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $13,000 | 0.0% | 12,000 | 0.0% | 0.01% | -11.1% |
Q4 2015 | $13,000 | -55.2% | 12,000 | 0.0% | 0.01% | -57.1% |
Q3 2015 | $29,000 | -39.6% | 12,000 | 0.0% | 0.02% | -34.4% |
Q2 2015 | $48,000 | -2.0% | 12,000 | 0.0% | 0.03% | 0.0% |
Q1 2015 | $49,000 | – | 12,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MERIDIAN INVESTMENT COUNSEL INC. | 50,000 | $76,000 | 0.05% |
FNY Partners Fund LP | 8,300 | $12,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 37 | $0 | 0.00% |
NORTHERN TRUST CORP | 12,539 | $19,000 | 0.00% |
BlackRock Inc. | 5,147 | $8,000 | 0.00% |
VANGUARD GROUP INC | 38,598 | $59,000 | 0.00% |